Key Takeaways OraSure submitted FDA applications for a rapid CT/NG self-test and the Colli-Pee at-home urine device.OSUR says the filings support its plan to move STI testing from centralized labs to at-home use.OSUR shares rose 3.8% after the news, moving the company closer to commercializing at-home STI testing.OraSure Technologies(OSUR) recently announced that it submitted two applications to the FDA seeking approval for its two new at-home tests for sexually transmitted infections (STIs), aiming to expa ...